News

Pharmetheus is a proud partner of the SweDeliver (The Swedish Drug Delivery Center) initiative that recently was identified as being critical to the technological development in Sweden and awarded a position on

Tomas Salmonson, formerly occupying senior positions at the Medical Products Agency, Sweden, recently joined Pharmetheus’ Board of Directors, and we couldn’t be prouder. Tomas’ many years at the Medical Products Agency, during

We are happy to have Joakim Hellner on board as an Associate Data Programmer. His experience includes data processing, data visualization and full stack web development. Based in Sweden, Joakim is working

Are you interested in a Ph.D. position linking Pharmetheus with two leading centers, Sanofi and the School of Pharmacy at Aix Marseille University? Join us in advancing PBPK modeling of subcutaneously administered

Will you attend Page 2022 and would benefit from additional insights on a) leveraging in vitro data or b) interpreting covariate effects in models? We have a few last spots left in

It is our pleasure to introduce Anna Mc Laughlin, Associate Consultant, who recently joined Pharmetheus. Anna’s experience includes pharmacometrics and model-informed precision dosing in oncology and immuno-oncology, especially in cellular therapies, oral

In 2021, the FDA granted an accelerated approval to tepotinib for metastatic non-small cell lung cancer. Earlier on, tepotinib had been approved for the treatment of advanced non-small cell lung cancer by

Pharmetheus is delighted to count Birgit Köster Hoffman among its new Board members. Birgit, an experienced international CEO and CFO, has developed an expertise as a Non Executive Board Professional in highly

Warmly welcoming Georgina Nilsson, as a new Project Coordinator to Pharmetheus. Georgina brings experience working in international teams, within marketing and project. See Georgina’s bio here.